Meadow Creek Wealth Advisors’s AbbVie ABBV Stock Holding History

Meadow Creek Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Sell	4,874 -758	-13%	-$163K	0.75%	32
2026 Q1	$1.22M	Sell	5,632 -41	-0.7%	-$9.1K	0.79%	28
2025 Q4	$1.3M	Sell	5,673 -13	-0.2%	-$2.96K	0.83%	26
2025 Q3	$1.29M	Buy	5,686 +296	+5%	+$60.3K	0.86%	24
2025 Q2	$1M	Buy	5,390 +485	+10%	+$90.1K	0.68%	32
2025 Q1	$1.03M	Buy	4,905 +81	+2%	+$15.7K	0.77%	32
2024 Q4	$857K	Sell	4,824 -90	-2%	-$16.5K	0.62%	37
2024 Q3	$970K	Buy	4,914 +361	+8%	+$67.4K	0.77%	33
2024 Q2	$781K	Buy	4,553 +345	+8%	+$57.1K	0.74%	35
2024 Q1	$766K	Buy	4,208 +22	+0.5%	+$3.79K	0.53%	46
2023 Q4	$649K	Buy	+4,186	New	+$610K	0.63%	39
2022 Q3	$489K	Buy	3,647 +91	+3%	+$13.1K	0.65%	38
2022 Q2	$545K	Sell	3,556 -395	-10%	-$60.4K	0.67%	33
2022 Q1	$640K	Sell	3,951 -1,212	-23%	-$176K	0.69%	35
2021 Q4	$699K	Buy	+5,163	New	+$610K	0.66%	30
2019 Q4	$501K	Buy	+5,653	New	+$469K	0.69%	46

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Meadow Creek Wealth Advisors's ABBV Position: Q2 2026 in Review

Meadow Creek Wealth Advisors reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $163K and leaving 4,874 shares worth $1.23M. The position accounts for 0.75% of the portfolio, ranked #32.

Meadow Creek Wealth Advisors first reported a position in ABBV in Q4 2019 and has held it in 16 quarters since. The position peaked at $1.3M in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Meadow Creek Wealth Advisors held 4,874 shares of AbbVie worth $1.23M as of Q2 2026.
Meadow Creek Wealth Advisors sold 758 AbbVie shares in Q2 2026, an estimated $163K.
AbbVie made up 0.75% of Meadow Creek Wealth Advisors's portfolio in Q2 2026, its #32 holding.
Meadow Creek Wealth Advisors first reported a position in AbbVie in Q4 2019 and has held it in 16 quarters since.
Meadow Creek Wealth Advisors's AbbVie position peaked at $1.3M in Q4 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Meadow Creek Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.